ZEPATIER
NDC 0006-3074, elbasvir and grazoprevir, tablet, film coated, from Merck Sharp & Dohme LLC.
- Product NDC
- 0006-3074
- Status
- Listed
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208261
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3074 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ELBASVIR50 mg/1
- GRAZOPREVIR ANHYDROUS100 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HCV NS3/4A Protease Inhibitors [MoA]; Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]; Hepatitis C Virus NS5A Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0006-3074-02 | 00006307402 | 2 DOSE PACK in 1 CARTON (0006-3074-02) / 14 TABLET, FILM COATED in 1 DOSE PACK (0006-3074-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/164dc02a-9180-426a-b8b5-04ab39d2bbd4
Use it
Look up 0006-3074 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3074 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0006-3074. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.